(Q52601683)

4 May 2018

title

A new method for tumor imaging by targeting cancer associated fibroblasts. (English)

1 reference

4 May 2018

4

Jürgen Debus

1 reference

4 May 2018

3

Walter Mier

1 reference

4 May 2018

author name string

Anastasia Loktev

1

1 reference

4 May 2018

Thomas Lindner

2

1 reference

4 May 2018

Annette Altmann

5

1 reference

4 May 2018

Dirk Jäger

6

1 reference

4 May 2018

Frederik Giesel

7

1 reference

4 May 2018

Clemens Kratochwil

8

1 reference

4 May 2018

Philippe Barthe

9

1 reference

4 May 2018

Christian Roumestand

10

1 reference

4 May 2018

Uwe Haberkorn

11

1 reference

4 May 2018

language of work or name

English

0 references

publication date

6 April 2018

1 reference

4 May 2018

The Journal of Nuclear Medicine

published in

1 reference

4 May 2018

Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Evaluation of the radiolabeled boronic acid-based FAP inhibitor MIP-1232 for atherosclerotic plaque imaging.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

An introduction to PET-CT imaging

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Requirements and implementation of a flexible kinetic modeling tool.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6126438

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts

2 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29626120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29626120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2967/JNUMED.118.210435

1 reference

4 May 2018

PMC publication ID

6126438

0 references

1 reference

4 May 2018